LT2006036A - Vakcinos kompozicijos mišinys su alkilfosfatidilcholinu - Google Patents

Vakcinos kompozicijos mišinys su alkilfosfatidilcholinu

Info

Publication number
LT2006036A
LT2006036A LT2006036A LT2006036A LT2006036A LT 2006036 A LT2006036 A LT 2006036A LT 2006036 A LT2006036 A LT 2006036A LT 2006036 A LT2006036 A LT 2006036A LT 2006036 A LT2006036 A LT 2006036A
Authority
LT
Lithuania
Prior art keywords
alkylphosphatidylcholine
vaccine composition
composition admixed
admixed
phosphatidylcholine
Prior art date
Application number
LT2006036A
Other languages
English (en)
Other versions
LT5435B (lt
Inventor
Jean Haensler
Original Assignee
Sanofi Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur filed Critical Sanofi Pasteur
Publication of LT2006036A publication Critical patent/LT2006036A/lt
Publication of LT5435B publication Critical patent/LT5435B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Išradimas yra susijęs su farmacine kompozicija, turinčia bent vieno vakcinos antigeno. Išradimo kompozicija yra besiskirianti tuo, kad joje yra bent vieno fosfatidilcholino fosfatinio esterio darinio, kurio struktūra atitinka I formulę, kurioje R1 yra žemesnysis alkilas, o R2 ir R3 yra vienodi arbaskirtingi, ir kiekvienas iš jų gali reikšti linijinio angliavandenilio grandines, turinčias 13-21 anglies atomą.
LT2006036A 2003-11-17 2006-05-17 Vakcinos kompozicijos mišinys su alkilfosfatidilcholinu LT5435B (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0313406A FR2862306B1 (fr) 2003-11-17 2003-11-17 Composition vaccinale

Publications (2)

Publication Number Publication Date
LT2006036A true LT2006036A (lt) 2007-05-25
LT5435B LT5435B (lt) 2007-07-25

Family

ID=34508504

Family Applications (1)

Application Number Title Priority Date Filing Date
LT2006036A LT5435B (lt) 2003-11-17 2006-05-17 Vakcinos kompozicijos mišinys su alkilfosfatidilcholinu

Country Status (23)

Country Link
US (2) US7344720B2 (lt)
EP (1) EP1696954B1 (lt)
JP (1) JP4638880B2 (lt)
KR (1) KR101136107B1 (lt)
CN (1) CN1882358B (lt)
AT (1) ATE412429T1 (lt)
AU (1) AU2004290943B2 (lt)
BR (1) BRPI0416670A (lt)
CA (1) CA2545086C (lt)
CY (1) CY1108498T1 (lt)
DE (1) DE602004017504D1 (lt)
DK (1) DK1696954T3 (lt)
ES (1) ES2311875T3 (lt)
FR (1) FR2862306B1 (lt)
IL (1) IL175573A (lt)
LT (1) LT5435B (lt)
LV (1) LV13457B (lt)
NO (1) NO20062779L (lt)
PL (1) PL1696954T3 (lt)
PT (1) PT1696954E (lt)
SI (1) SI1696954T1 (lt)
WO (1) WO2005049080A1 (lt)
ZA (1) ZA200603522B (lt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100752990B1 (ko) * 2006-08-02 2007-08-30 주식회사 대웅 나노리포좀 및 천연 추출물을 포함하는 피부 질환의 예방또는 치료용 조성물
TWI444384B (zh) * 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
CN101959527B (zh) 2008-03-05 2016-04-20 赛诺菲巴斯德有限公司 一种使含佐剂的疫苗组合物稳定的方法
WO2010130896A2 (fr) 2009-05-14 2010-11-18 Sanofi Pasteur Procédé pour adjuver le lipopolysaccharide (lps) des bactéries à gram-négatif
CA2761924C (fr) 2009-05-14 2017-10-31 Sanofi Pasteur Vaccin meningocoque a base de lipooligosaccharide (los) provenant de souches modifiees de neisseria meningitidis d'immunotype l6
AU2010247253A1 (en) * 2009-05-14 2012-01-12 Sanofi Pasteur Method for detoxification of lipopolysaccharide (LPS) or of lipid a of gram-negative bacteria
EP2578974A1 (en) 2011-10-05 2013-04-10 Sanofi Pasteur Sa Process line for the production of freeze-dried particles
JP5761143B2 (ja) * 2011-11-02 2015-08-12 株式会社リコー 撮像ユニット、撮像ユニットを搭載した車両
US20140147475A1 (en) * 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
AU2014234452B2 (en) 2013-03-18 2018-02-22 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by Mannheimia haemolytica
BR112016031039B1 (pt) 2014-07-21 2022-02-15 Sanofi Pasteur Sa Dispositivo de alimentação de líquido para a geração de gotículas, linha de processo para a produção de partículas liofilizadas e processos para preparar uma composição de vacina compreendendo

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100064A (en) 1984-04-06 2000-08-08 Chiron Corporation Secreted viral proteins useful for vaccines and diagnostics
FR2773156B1 (fr) 1997-12-26 2000-03-31 Biovacs Inc Nouveaux immunogenes anti-retroviraux (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
ES2260291T3 (es) 2000-09-28 2006-11-01 Chiron Corporation Microparticulas para la administracion de acidos nucleicos heterologos.
DE60117164T2 (de) * 2000-11-07 2006-08-03 Immuno Vaccine Technologies Inc., Halifax Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung
US7303881B2 (en) * 2004-04-30 2007-12-04 Pds Biotechnology Corporation Antigen delivery compositions and methods of use

Also Published As

Publication number Publication date
ZA200603522B (en) 2007-07-25
ES2311875T3 (es) 2009-02-16
IL175573A0 (en) 2006-09-05
SI1696954T1 (sl) 2009-04-30
CN1882358B (zh) 2011-02-02
FR2862306A1 (fr) 2005-05-20
WO2005049080A1 (fr) 2005-06-02
FR2862306B1 (fr) 2008-05-30
US7767658B2 (en) 2010-08-03
US7344720B2 (en) 2008-03-18
EP1696954B1 (fr) 2008-10-29
CY1108498T1 (el) 2014-04-09
US20050208060A1 (en) 2005-09-22
EP1696954A1 (fr) 2006-09-06
CN1882358A (zh) 2006-12-20
PT1696954E (pt) 2008-11-25
WO2005049080B1 (fr) 2005-09-01
ATE412429T1 (de) 2008-11-15
AU2004290943A1 (en) 2005-06-02
AU2004290943B2 (en) 2009-08-27
LV13457B (en) 2007-01-20
PL1696954T3 (pl) 2009-04-30
US20080131446A1 (en) 2008-06-05
KR101136107B1 (ko) 2012-04-17
CA2545086C (en) 2011-11-08
CA2545086A1 (en) 2005-06-02
DK1696954T3 (da) 2009-02-23
DE602004017504D1 (de) 2008-12-11
IL175573A (en) 2010-06-30
JP2007511585A (ja) 2007-05-10
JP4638880B2 (ja) 2011-02-23
NO20062779L (no) 2006-08-15
KR20060127385A (ko) 2006-12-12
BRPI0416670A (pt) 2007-02-13
LT5435B (lt) 2007-07-25

Similar Documents

Publication Publication Date Title
LT2006036A (lt) Vakcinos kompozicijos mišinys su alkilfosfatidilcholinu
ATE407993T1 (de) Alkoxylierte alkylphenole und deren verwendung in kraft- und schmierstoffen
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
CY1112214T1 (el) Ενωσεις για χρησεις σχετιζομενες με φλεγμονες και το ανοσοποιητικο
YU96902A (sh) Glikopeptidni fosfonatni derivati
AU2002367396A1 (en) Phosphate transport inhibitors
CY1111234T1 (el) Αραιωτικα για αντιστροφα γαλακτωματα
BRPI0507312A (pt) derivados de quinolina para uso como inibidores micobacterianos
TW200509949A (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
TW200722421A (en) Azole derivatives as inhibitors of lipases and phospholipases
ES2192031T3 (es) Nuevas amidas aromaticas, su procedimiento de preparacion y su aplicacion como medicamentos.
NO20074005L (no) Antisugvaeske til bruk i underjordiske formasjoner
MXPA05010607A (es) Composiciones de distribucion de farmacos de ester de alfa-hidroxiacido y metodos de uso.
WO2005046672A3 (fr) Utilisation d’inhibiteurs de glucosidase pour une therapie de la mucoviscidose
PE61196A1 (es) Aceite base para fluidos de penetracion de pozos
SE0003476D0 (sv) Compounds
CO5070654A1 (es) Derivados de acidos fenilaminoalquilcarboxilicos y composiciones farmaceuticas que los comprenden
DE60109202D1 (de) Pharmazeutische aerosolformulierung
CY1107599T1 (el) Παραγωγα του οκταϋδρο-6, 10-διοξο-6h-πυριδαζινο [1,2-α] [1,2] διαζεπινη-1-καρβοξυλικου οξεος, η διαδικασια παρασκευης τους και η εφαρμογη τους στην παρασκευη θepαπευτικα ενepγων ενωσεων
AU2002210425A1 (en) Novel beta-amyloid inhibitors, method for producing the same and the use thereofas medicaments
ECSP066548A (es) 4-anilino-3-quinolincarbonitrilos para el tratamiento de leucemia mielogena cronica
EP1264594A3 (en) Melanin production inhibitors and skincare products containing such inhibitors
CO5040175A1 (es) Composicion de limpieza para superficies duras que contienen un diester de glicol polialcoxileno
EA200400211A1 (ru) Лиофилизованная композиция 2-метилтиенобензодиазепина
TW200503772A (en) Water-in-oil emulsified composition

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20131115